203 related articles for article (PubMed ID: 31650411)
21. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
[TBL] [Abstract][Full Text] [Related]
22. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
[TBL] [Abstract][Full Text] [Related]
23. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Santella C; Bitton A; Filliter C; Bessissow T; Vutcovici M; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2022 Feb; 28(2):176-182. PubMed ID: 33999136
[TBL] [Abstract][Full Text] [Related]
24. Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies.
Pineton de Chambrun G; Dauchet L; Gower-Rousseau C; Cortot A; Colombel JF; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1405-15.e1; quiz e130. PubMed ID: 25956840
[TBL] [Abstract][Full Text] [Related]
25. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
Zhang XY; Dong HC; Wang WF; Zhang Y
World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
[TBL] [Abstract][Full Text] [Related]
26. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
[TBL] [Abstract][Full Text] [Related]
27. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
28. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.
Masunaga Y; Ohno K; Ogawa R; Hashiguchi M; Echizen H; Ogata H
Ann Pharmacother; 2007 Jan; 41(1):21-8. PubMed ID: 17200426
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
[TBL] [Abstract][Full Text] [Related]
32. Risk of Stroke in Patients with Herpes Zoster: A Systematic Review and Meta-Analysis.
Yang SY; Li HX; Yi XH; Han GL; Zong Q; Wang MX; Peng XX
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):301-307. PubMed ID: 27810150
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
Wu XW; Wu L; Ji HZ; Wang FY
Dig Dis Sci; 2015 Nov; 60(11):3203-8. PubMed ID: 26031424
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive, updated systematic review and meta-analysis of epidemiologic evidence on the connection between herpes zoster infection and the risk of stroke.
Heiat M; Salesi M; Peypar MH; Ramazani A; Abdorrashidi M; Yeganeh AV
Rev Med Virol; 2024 Jul; 34(4):e2556. PubMed ID: 38853706
[TBL] [Abstract][Full Text] [Related]
35. Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis.
Guo X; Yan M
Immunol Invest; 2017 Aug; 46(6):566-576. PubMed ID: 28742404
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease.
Caldera F; Spaulding AC; Borah B; Moriarty J; Zhu Y; Hayney MS; Farraye FA
Aliment Pharmacol Ther; 2023 Jun; 57(11):1326-1334. PubMed ID: 36896952
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.
De Felice KM; Novotna M; Enders FT; Faubion WA; Tremaine WJ; Kantarci OH; Raffals LE
Aliment Pharmacol Ther; 2015 Jan; 41(1):99-107. PubMed ID: 25348720
[TBL] [Abstract][Full Text] [Related]
38. Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
Nugent Z; Singh H; Targownik LE; Bernstein CN
Inflamm Bowel Dis; 2019 Feb; 25(3):532-540. PubMed ID: 30085137
[TBL] [Abstract][Full Text] [Related]
39. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
